Health news Novo Nordisk CEO steps down amid competition for weight loss drugs Lars Fruergaard Jørgensen, who has led the pharmaceutical giant since 2017, joined the firm in 1991. 16/05/2025
Health news EU regulators block new Alzheimer’s drug over side effects The company behind the drug donanemab said it will ask regulators to reconsider the decision. 28/03/2025
Healthcare Italy spent over €1 billion on dozens of ‘drugs to avoid’ in 2022 An independent researcher said the results should spark a re-evaluation of some medicines, but do not necessarily mean patients are being harmed. 20/11/2024
Business Doliprane-maker Sanofi confirms exclusive talks with US firm CD&R The American private equity firm has agreed to French government demands about protecting jobs and investment in France. 21/10/2024
Healthcare Global leaders commit to curbing antibiotic resistance by 2030 The UN agreement calls for global cooperation to protect people from superbugs that can evade antibiotic drugs. 26/09/2024
Health news Agency chief seeks help from pharma industry with medicines shortages Greater transparency between regulators and manufacturers can foster a better understanding of supply chain vulnerabilities and reduce risks of drug shortages, European Medicines Agency (EMA) Executive Director Emer Cooke told Euronews in an interview. 04/04/2024
Business Novo Nordisk looks to expand into heart disease treatment The Novo Nordisk deal is due to be wrapped up in the second quarter of this year. It will help to establish the maker of Wegovy and Ozempic in the cardiovascular treatment market. 26/03/2024
Business Drugmaker Novo Nordisk reaches market value of $500 million Demand for obesity drugs has pushed Novo Nordisk's share price to new highs. 31/01/2024
Green News Plan for €400 million monkey-breeding facility in US sparks protest The facility would eventually hold up to 30,000 long-tailed macaques that would be sold to universities and pharmaceutical companies for medical research. 18/01/2024
Health news Americans turn to alternatives amid Ozempic shortage Approved in 2017 for adults with type 2 diabetes, Ozempic has now become a blockbuster weight loss drug. 04/12/2023
Business Sales skyrocket for weight-loss drug firm Novo Nordisk The Danish drugmaker expects double-digit growth to continue into 2024 as demand soars for obesity and diabetes medication. 02/11/2023
Health news Woman cured of bowel cancer in 6 months after receiving new drug A 42-year-old woman had no evidence of cancer after receiving the drug dostarlimab which is still in early trials for treatment of a rare form of colorectal cancer. 09/10/2023
World News Europe key to Syrian regime's amphetamine trade, finds report Europe has become the main transit route for Syrian Captagon tablets heading to the Middle East, according to the EMCDDA. 24/09/2023
Markets Novo Nordisk topples LVMH as Europe's most valuable company The Danish drugmaker has ended French luxury group LVMH's two-and-a-half-year reign as the most valuable company in Europe. 05/09/2023
Health news Weight-loss drug Wegovy could reduce risk of heart attack or stroke Danish pharmaceutical company Novo Nordisk says the medicine could reduce the risk of cardiovascular disease. But they’re also facing a lawsuit about severe side effects of its main ingredient. 09/08/2023
Health news New Alzheimer’s drug gets full approval from US regulators The treatment received conditional approval in January, but received full approval following a review of data from a further 1,800 patient study that showed the drug slowed cognitive decline by 5 months. 07/07/2023
Health news Move over, CBD: HHC is the new ‘legal cannabis’ causing concern After the boom of CBD, authorities worry about HHC, which can be ingested, smoked or vaped, with effects similar to those of cannabis. 25/05/2023
Healthcare Recreational cannabis goes on sale in some Swiss pharmacies A new pilot aims to assess the health effects of regulating cannabis supply in the Swiss city of Basel - and soon in Zurich, Geneva, and Lausanne. 30/03/2023
Health news Biden urges drug giants to slash insulin prices after Eli Lilly’s move "It’s a big deal, and it’s time for other manufacturers to follow," the US president said. 02/03/2023
Health news Cannabis start-ups blooming as Germany eyes legal recreational use German start-ups growing cannabis for medical use - legal in the country since 2016 - are booming. What impact will a move to recreational use have? 03/01/2022